november 25, 2022

Ectin Research AB recruits Dr. Kevan Cassidy to lead the company’s CMC developmental work

Ectin Research has recruited Dr. Kevan Cassidy as Director, Technical Operations to lead the company’s development work in Clinical Manufacturing and Control (CMC) and formulation. He is a trained pharmacist with a doctorate in Drug Metabolism and Pharmacokinetics with great interest and experience in formulation development, pharmacokinetics, and regulatory issues in drug development.

Dr. Kevan Cassidy has been recruited as a consultant to lead the company’s development work within Clinical Manufacturing and Control and formulation. Dr. Kevan Cassidy is a pharmacist with a PhD in Drug Metabolism and Pharmacokinetics at the University of Manchester, England. He has a strong interest in drug development and held several different senior strategic positions focusing on formulation, pharmacokinetics, regulatory issues, and clinical trials within primary generics companies. He is currently ’Director and founder’ at Biokinetix Ltd. A consulting company with a focus on product development and regulatory activities within the pharmaceutical industry. Before that he was, for example, ’Product development manager’ Consilient Health Ltd, ’Clinical Director’ Perrigo/Rosemont Pharmaceuticals, ’R&D Director’ Rosemont Pharmaceuticals and ’VP Global Head Clinical’ Mylan Inc. as well as ’R&D Director’ Merck-Generics Group Europe.

Ectin Research’s CEO Anna Sjöblom-Hallén: ”We are extremely pleased with our recruitment of Dr. Kevan Cassidy, a very senior CMC expert with solid expertise in drug development. He will drive the company’s issues in the field of CMC and formulation development onwards”